Description
Provide a narrative summary of what is contained in this registration or how it differs from prior registrations. If this project contains documents for a preregistration, please note that here.
This study protocol outlines the methodology for the co-creational approach of the project “Social Prescribing to Promote and Improve Access to Health and Care Services for People in Vulnerable Situations in Europe” (SP-EU). Social Prescribing (SP) is an innovative approach that addresses social problems in primary care by linking medical care with social supports and services in the community. While early evidence points at the positive impact of SP regarding health-related social problems, SP has not been tailored to the specific needs, preferences and contexts of vulnerable groups.
The objective of this subproject is to adapt SP to specific needs in a co-creational approach that directly involves three vulnerable populations:
a) lesbian, gay, bisexual, transgender, inter, queer (LGBTIQ) individuals
b) refugees and first-generation immigrants
c) older adults living alone.
Following a co-creation framework adapted to our specific setting, the co-creation process is divided into three phases:
Phase 1 involves conducting a rapid review of SP manuals and protocols, with a focus on recruitment of patients, training of GPs, training of link workers, outcome measurements, and integration of equity and diversity perspectives. Additionally, workshops are held with LGBTIQ persons, refugees/first-generation immigrants, and older adults living alone to develop case vignettes.
Phase 2 consists of conducting two workshops per vulnerable group that combines the developed case vignettes and the results of the rapid review to discuss necessary adaptations. The involved research teams will consult and exchange results between workshops to ensure comprehensive adaptations.
Phase 3 includes discussing preliminary adaptations at local advisory boards across Europe. Finally, a consensus conference is held to finalize and document the three co-created SP adaptations for use in a pragmatic randomized controlled trial to test their effectiveness.
This study protocol outlines the methodology for the co-creational approach of the project “Social Prescribing to Promote and Improve Access to Health and Care Services for People in Vulnerable Situations in Europe” (SP-EU). Social Prescribing (SP) is an innovative approach that addresses social problems in primary care by linking medical care with social supports and services in the community. While early evidence points at the positive impact of SP regarding health-related social problems, SP has not been tailored to the specific needs, preferences and contexts of vulnerable groups.
The objective of this subproject is to adapt SP to specific needs in a co-creational approach that directly involves three vulnerable populations:
a) lesbian, gay, bisexual, transgender, inter, queer (LGBTIQ) individuals
b) refugees and first-generation immigrants
c) older adults living alone.
Following a co-creation framework adapted to our specific setting, the co-creation process is divided into three phases:
Phase 1 involves conducting a rapid review of SP manuals and protocols, with a focus on recruitment of patients, training of GPs, training of link workers, outcome measurements, and integration of equity and diversity perspectives. Additionally, workshops are held with LGBTIQ persons, refugees/first-generation immigrants, and older adults living alone to develop case vignettes.
Phase 2 consists of conducting two workshops per vulnerable group that combines the developed case vignettes and the results of the rapid review to discuss necessary adaptations. The involved research teams will consult and exchange results between workshops to ensure comprehensive adaptations.
Phase 3 includes discussing preliminary adaptations at local advisory boards across Europe. Finally, a consensus conference is held to finalize and document the three co-created SP adaptations for use in a pragmatic randomized controlled trial to test their effectiveness.
| Date made available | 17 Mar 2025 |
|---|---|
| Publisher | OSF Registries |